Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $12.93B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
ANI Pharmaceuticals USD 1.59B 293M Aug/2026
Ardelyx USD 1.48B 63M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 324.18B 6.81B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pacira USD 1.28B 286M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Supernus Pharmaceuticals USD 2.58B 116M Aug/2026
TG Therapeutics USD 7.63B 778M Aug/2026